December 15, 2022
Shakira Grant, MBBS, the studies’ principal investigator, shared the findings during oral presentations at the annual meeting of the American Society of Hematology (ASH) in New Orleans.
December 15, 2022
Lindsey James, PhD, is well-suited to the collaborative relationship between UNC Lineberger and UNC Eshelman School of Pharmacy, taking her interests in medicinal chemistry and epigenetics and working with cancer center physicians and researchers to make strides into cancer care and treatment.
September 27, 2022
The UNC Lineberger annual scientific retreat featured faculty talks covering a range of basic, clinical/translational and population science research, as well as a poster session.
September 20, 2022
As a tribute to the legacy of the late Marc Basnight, the former state senate president pro tempore who passed away in 2020, the building was officially renamed the North Carolina Basnight Cancer Hospital.
August 30, 2022
Nothing brings smiles to faces in the N.C. Cancer Hospital like four-legged staff member Cheese, a Golden Retriever and therapy dog.
July 27, 2022
As a college professor specializing in military history, Dick Kohn is used to exploring the successes and failures of the past and looking at them through a current lens. But Kohn’s history with cancer is one area of his past that he is glad to see in the rearview mirror.
July 14, 2022
Inspired by the potential of immunotherapy in solid tumor cancers, Tom and Nancy Chewning established a fund to support Jonathan Serody, MD, and accelerate his work with CAR-T immunotherapy.
June 26, 2022
Sascha Tuchman, MD, MHS, specializes in hematology, and specifically multiple myeloma and amyloidosis. At UNC Lineberger, he collaborates with other UNC Lineberger clinicians and scientists, and works to cultivate the next generation of myeloma experts.
June 7, 2022
On May 31, the Get Real & Heel facility reopened its doors to patients, friends and visitors, welcoming them back to a transformed space. The space features state-of-the-art equipment, updated locker rooms and an open-air concept that is a different look from the original.
June 5, 2022
Hanna K. Sanoff, MD, MPH, is the author of a viewpoint that provides a perspective on the evolving treatment of rectal cancer in light of findings from a phase II clinical trial using the drug dostarlimab.
